HRTS Holdings Information

HRTS is an equity ETF with a total of 46 individual holdings. The top holdings are Eli Lilly and Company stock at 8.83%, UnitedHealth Group at 4.97%, AstraZeneca at 4.37%, Roche Holding AG at 4.31%, and Abbott Laboratories at 4.17%.

Total Holdings

Top 10 Percentage

44.09%

Asset Class

Equity

ETF Category

Health

Assets

50.65M

PE Ratio

21.19

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	8.83%	5,424
2	UNH	UnitedHealth Group Incorporated	4.97%	7,017
3	LON: AZN	AstraZeneca PLC	4.37%	13,038
4	RHHBY	Roche Holding AG	4.31%	48,502
5	ABT	Abbott Laboratories	4.17%	16,433
6	GILD	Gilead Sciences, Inc.	3.86%	16,499
7	TMO	Thermo Fisher Scientific Inc.	3.62%	3,396
8	BSX	Boston Scientific Corporation	3.54%	18,213
9	ABBV	AbbVie Inc.	3.26%	7,229
10	SWX: NOVN	Novartis AG	3.16%	12,089
11	MDT	Medtronic plc	3.11%	16,474
12	JNJ	Johnson & Johnson	2.91%	7,635
13	CPH: NOVO.B	Novo Nordisk A/S	2.77%	24,359
14	CYTK	Cytokinetics, Incorporated	2.48%	21,182
15	VRTX	Vertex Pharmaceuticals Incorporated	2.47%	3,040
16	DHR	Danaher Corporation	2.44%	5,823
17	ARWR	Arrowhead Pharmaceuticals, Inc.	2.42%	31,201
18	MRK	Merck & Co., Inc.	2.31%	13,843
19	BBIO	BridgeBio Pharma, Inc.	2.08%	18,981
20	ALNY	Alnylam Pharmaceuticals, Inc.	2.05%	2,149
21	AMGN	Amgen Inc.	2.03%	3,449
22	REGN	Regeneron Pharmaceuticals, Inc.	1.95%	1,728
23	MCK	McKesson Corporation	1.91%	1,238
24	CRNX	Crinetics Pharmaceuticals, Inc.	1.84%	21,883
25	EW	Edwards Lifesciences Corporation	1.79%	12,369

Showing 25 of 46 holdings

Subscribe to see the full list

Activate Now

As of Oct 16, 2025